Exai Bio: Karen Knudsen

Exai Bio, a company developing RNA and AI-enabled liquid biopsy for early cancer detection, has appointed Karen Knudsen to its board of directors. Knudsen is the former CEO of the American Cancer Society and its affiliate, the American Cancer Society Cancer Action Network. Prior to leading ACS, Knudsen served as executive VP of oncology services and enterprise director of the Sidney Kimmel Comprehensive Cancer Center at Jefferson Health. She also served as president of the Association of American Cancer Institutes and was a member of the National Cancer Institute's board of scientific advisors.